West to Host Second-Quarter 2025 Conference Call
West Pharmaceutical Services (NYSE: WST), a global leader in injectable drug administration solutions, will release its second-quarter 2025 financial results before market open on Thursday, July 24, 2025.
The company will host a conference call at 8:00 a.m. Eastern Time to discuss results and business expectations. Participants must pre-register to ask questions during the call. A slide presentation will be available in the Investors section of West's website, and a webcast replay will be accessible for approximately 90 days following the event.
West Pharmaceutical Services (NYSE: WST), leader mondiale nelle soluzioni per la somministrazione di farmaci iniettabili, pubblicherà i suoi risultati finanziari del secondo trimestre 2025 prima dell'apertura dei mercati, giovedì 24 luglio 2025.
L'azienda terrà una conference call alle 8:00 ora della costa orientale per discutere i risultati e le aspettative di business. I partecipanti devono registrarsi in anticipo per poter porre domande durante la chiamata. Una presentazione in formato slide sarà disponibile nella sezione Investitori del sito web di West, e la registrazione della webcast sarà accessibile per circa 90 giorni dopo l'evento.
West Pharmaceutical Services (NYSE: WST), líder mundial en soluciones para la administración de medicamentos inyectables, publicará sus resultados financieros del segundo trimestre de 2025 antes de la apertura del mercado el jueves 24 de julio de 2025.
La compañía realizará una llamada conferencia a las 8:00 a.m., hora del Este para discutir los resultados y las expectativas comerciales. Los participantes deben registrarse previamente para poder hacer preguntas durante la llamada. Una presentación en diapositivas estará disponible en la sección de Inversores del sitio web de West, y la repetición de la transmisión estará accesible aproximadamente por 90 días después del evento.
West Pharmaceutical Services (NYSE: WST)는 주사제 투여 솔루션 분야의 글로벌 선두주자로서, 2025년 2분기 재무 실적을 2025년 7월 24일 목요일 시장 개장 전 공개할 예정입니다.
회사는 동부 표준시 기준 오전 8시에 실적 및 사업 전망에 대해 논의하는 컨퍼런스 콜을 진행합니다. 참가자는 콜 중 질문을 하기 위해 사전 등록해야 합니다. 슬라이드 발표 자료는 West 웹사이트의 투자자 섹션에서 제공되며, 웹캐스트 녹화는 행사 후 약 90일간 시청할 수 있습니다.
West Pharmaceutical Services (NYSE : WST), leader mondial des solutions d'administration de médicaments injectables, publiera ses résultats financiers du deuxième trimestre 2025 avant l'ouverture des marchés le jeudi 24 juillet 2025.
L'entreprise tiendra une conférence téléphonique à 8h00 heure de l'Est pour discuter des résultats et des perspectives commerciales. Les participants doivent s'inscrire à l'avance pour pouvoir poser des questions lors de l'appel. Une présentation en diaporama sera disponible dans la section Investisseurs du site Web de West, et la rediffusion du webcast sera accessible pendant environ 90 jours après l'événement.
West Pharmaceutical Services (NYSE: WST), ein weltweit führendes Unternehmen im Bereich injizierbarer Arzneimittellösungen, wird seine Finanzergebnisse für das zweite Quartal 2025 vor Börsenöffnung am Donnerstag, den 24. Juli 2025 veröffentlichen.
Das Unternehmen veranstaltet um 8:00 Uhr Eastern Time eine Telefonkonferenz, um die Ergebnisse und Geschäftserwartungen zu besprechen. Teilnehmer müssen sich vorab registrieren, um während des Anrufs Fragen stellen zu können. Eine Präsentation in Folienform wird im Investor-Bereich der West-Website verfügbar sein, und eine Webcast-Wiedergabe wird etwa 90 Tage nach der Veranstaltung zugänglich sein.
- None.
- None.
The live webcast can be accessed by clicking here. To ask questions on the conference call, participants need to register in advance by clicking here. Registered telephone participants will receive the dial-in number along with a unique PIN number that will enable them to ask questions on the call.
A slide presentation will be made available on the day of the call in the Investors section of the Company's website. A replay of the webcast will be available on the Company's website for approximately 90 days after the event.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.
Headquartered in
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-host-second-quarter-2025-conference-call-302499084.html
SOURCE West Pharmaceutical Services, Inc.
FAQ
When will West Pharmaceutical Services (WST) release Q2 2025 earnings?
What time is West Pharmaceutical Services Q2 2025 earnings call?
How can I participate in West Pharmaceutical Services (WST) Q2 2025 earnings call?
How long will West Pharmaceutical Services Q2 2025 earnings call replay be available?
